Literature DB >> 26051940

ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis.

Takashi Izawa1, Nidhi Rohatgi1, Tomohiro Fukunaga1, Qun-Tian Wang2, Matthew J Silva3, Michael J Gardner3, Michael L McDaniel1, Nada A Abumrad4, Clay F Semenkovich5, Steven L Teitelbaum6, Wei Zou7.   

Abstract

ASXL2 is an ETP family protein that interacts with PPARγ. We find that ASXL2-/- mice are insulin resistant, lipodystrophic, and fail to respond to a high-fat diet. Consistent with genetic variation at the ASXL2 locus and human bone mineral density, ASXL2-/- mice are also severely osteopetrotic because of failed osteoclast differentiation attended by normal bone formation. ASXL2 regulates the osteoclast via two distinct signaling pathways. It induces osteoclast formation in a PPARγ/c-Fos-dependent manner and is required for RANK ligand- and thiazolidinedione-induced bone resorption independent of PGC-1β. ASXL2 also promotes osteoclast mitochondrial biogenesis in a process mediated by PGC-1β but independent of c-Fos. Thus, ASXL2 is a master regulator of skeletal, lipid, and glucose homeostasis.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26051940      PMCID: PMC4472564          DOI: 10.1016/j.celrep.2015.05.019

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

1.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.

Authors:  Y P Li; W Chen; Y Liang; E Li; P Stashenko
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.

Authors:  Tomohiro Fukunaga; Wei Zou; Nidhi Rohatgi; Jerry R Colca; Steven L Teitelbaum
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

Review 3.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

4.  Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.

Authors:  Oxana P Lazarenko; Sylwia O Rzonca; William R Hogue; Frances L Swain; Larry J Suva; Beata Lecka-Czernik
Journal:  Endocrinology       Date:  2007-03-01       Impact factor: 4.736

5.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 6.  Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.

Authors:  Mohsen Janghorbani; Rob M Van Dam; Walter C Willett; Frank B Hu
Journal:  Am J Epidemiol       Date:  2007-06-16       Impact factor: 4.897

7.  PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis.

Authors:  Junichiro Sonoda; Isaac R Mehl; Ling-Wa Chong; Russell R Nofsinger; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

Review 8.  PPARγ signaling and metabolism: the good, the bad and the future.

Authors:  Maryam Ahmadian; Jae Myoung Suh; Nasun Hah; Christopher Liddle; Annette R Atkins; Michael Downes; Ronald M Evans
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

9.  Decreased c-Src expression enhances osteoblast differentiation and bone formation.

Authors:  M Marzia; N A Sims; S Voit; S Migliaccio; A Taranta; S Bernardini; T Faraggiana; T Yoneda; G R Mundy; B F Boyce; R Baron; A Teti
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

Review 10.  Functional and cancer genomics of ASXL family members.

Authors:  M Katoh
Journal:  Br J Cancer       Date:  2013-06-04       Impact factor: 7.640

View more
  27 in total

Review 1.  Metabolic reprogramming in osteoclasts.

Authors:  Kyung-Hyun Park-Min
Journal:  Semin Immunopathol       Date:  2019-09-24       Impact factor: 9.623

2.  ASXL2--director of skeletal and metabolic homeostasis.

Authors:  David Holmes
Journal:  Nat Rev Endocrinol       Date:  2015-06-23       Impact factor: 43.330

3.  ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.

Authors:  Nidhi Rohatgi; Wei Zou; Patrick L Collins; Jonathan R Brestoff; Timothy H Chen; Yousef Abu-Amer; Steven L Teitelbaum
Journal:  Blood Adv       Date:  2018-10-09

Review 4.  Glucose metabolism in bone.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Bone       Date:  2017-08-24       Impact factor: 4.398

5.  Reply to "PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation".

Authors:  Ronald M Evans; Yihong Wan
Journal:  Nat Med       Date:  2016-11-08       Impact factor: 53.440

6.  PGC1β Organizes the Osteoclast Cytoskeleton by Mitochondrial Biogenesis and Activation.

Authors:  Yan Zhang; Nidhi Rohatgi; Deborah J Veis; Joel Schilling; Steven L Teitelbaum; Wei Zou
Journal:  J Bone Miner Res       Date:  2018-03-11       Impact factor: 6.741

Review 7.  Nuclear receptors in osteoclasts.

Authors:  Seyeon Bae; Steven Zeng; Kyung-Hyun Park-Min
Journal:  Curr Opin Pharmacol       Date:  2020-06-20       Impact factor: 5.547

8.  Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure.

Authors:  Wei Zou; Nidhi Rohatgi; Jonathan R Brestoff; John R Moley; Yongjia Li; Jesse W Williams; Yael Alippe; Hua Pan; Terri A Pietka; Gabriel Mbalaviele; Elizabeth P Newberry; Nicholas O Davidson; Anwesha Dey; Kooresh I Shoghi; Richard D Head; Samuel A Wickline; Gwendalyn J Randolph; Nada A Abumrad; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

9.  De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.

Authors:  Vandana Shashi; Loren D M Pena; Katherine Kim; Barbara Burton; Maja Hempel; Kelly Schoch; Magdalena Walkiewicz; Heather M McLaughlin; Megan Cho; Nicholas Stong; Scott E Hickey; Christine M Shuss; Michael S Freemark; Jane S Bellet; Martha Ann Keels; Melanie J Bonner; Maysantoine El-Dairi; Megan Butler; Peter G Kranz; Constance T R M Stumpel; Sylvia Klinkenberg; Karin Oberndorff; Malik Alawi; Rene Santer; Slavé Petrovski; Outi Kuismin; Satu Korpi-Heikkilä; Olli Pietilainen; Palotie Aarno; Mitja I Kurki; Alexander Hoischen; Anna C Need; David B Goldstein; Fanny Kortüm
Journal:  Am J Hum Genet       Date:  2016-09-29       Impact factor: 11.025

Review 10.  The Role of Additional Sex Combs-Like Proteins in Cancer.

Authors:  Jean-Baptiste Micol; Omar Abdel-Wahab
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.